Sign Out
Posology: Adults: The recommended dose is one inhalation of INCRUSE 62.5 micrograms once daily.
INCRUSE should be administered once daily at the same time of the day each day to maintain bronchodilation. The maximum dose is one inhalation of INCRUSE 62.5 micrograms once daily.
Special populations: Elderly patients: No dosage adjustment is required in patients over 65 years (see Pharmacology: Pharmacokinetics under Actions).
Renal impairment: No dosage adjustment is required in patients with renal impairment (see Pharmacology: Pharmacokinetics under Actions).
Hepatic impairment: No dosage adjustment is required in patients with mild or moderate hepatic impairment.
INCRUSE has not been studied in patients with severe hepatic impairment and should be used with caution (see Pharmacology: Pharmacokinetics under Actions).
Paediatric population: There is no relevant use of INCRUSE in the paediatric population (under 18 years of age) in the indication for COPD.
Method of administration: INCRUSE is for inhalation use only.
